1,2-Dichloroethane → Nb-p-Coumaroyltryptamine
Reaktionsgleichung
[OH:1][C:2]1[CH:12]=[CH:11][C:5]([CH:6]=[CH:7][C:8]([OH:10])=O)=[CH:4][CH:3]=1.Cl.[NH2:14][CH2:15][CH2:16][C:17]1[C:25]2[C:20](=[CH:21][CH:22]=[CH:23][CH:24]=2)[NH:19][CH:18]=1.C(Cl)CCl.C(OCC)(=O)C>CCCCCC>[NH:19]1[C:20]2[C:25](=[CH:24][CH:23]=[CH:22][CH:21]=2)[C:17]([CH2:16][CH2:15][NH:14][C:8](=[O:10])/[CH:7]=[CH:6]/[C:5]2[CH:4]=[CH:3][C:2]([OH:1])=[CH:12][CH:11]=2)=[CH:18]1Komponenten
6
Edukt 4
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
(E)-N-(2-(1H-indol-3-yl)ethyl)-3-(4-hydroxyphenyl) acrylamide (2e) was synthesized by the condensation of 4-hydroxy cinnamic acid (150 mg, 0.914 mmol) and tryptamine hydrochloride (215 mg, 1.09 mmol) using standard EDC coupling method. 2e was isolated as yellowish solid (178 mg, 64%) by elution with 45% ethyl acetate in hexane. Rf: 0.593 (80% ethyl acetate in hexane); mp: 135-138° C.;
Quellen und Nachweise
- ORD-Eintrag
- ord-0524926c715c4b5199a05a759f2d58f7
- Quelldatensatz
- uspto-grants-2014_12
- Patentnummer
- US08901317B2
Notizen zur Reaktion
Wird geladen…